Wai Yuen Tong Sets 25 June Board Meeting to Approve FY 2026 Results and Final Dividend

Bulletin Express

Jun 11

Wai Yuen Tong Medicine Holdings Limited has scheduled a board meeting for 25 June 2026. The agenda includes consideration and approval of the audited consolidated results for the financial year ended 31 March 2026 and deliberation on a potential final dividend.

The notification, released on 11 June 2026, was signed by Company Secretary Ng Yee Man Fiona. The board currently comprises three executive directors—Tang Ching Ho, Tang Wai Man and Law Man Yee, Anita—alongside independent non-executive directors Li Ka Fai, David, Professor Sit Wing Hang and Professor Chan Wing Kwong.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1132195558"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1132195558\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1132195558?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1132195558","market":"hk","top_or_hot":-1,"title":"Wai Yuen Tong Sets 25 June Board Meeting to Approve FY 2026 Results and Final Dividend","media":"Bulletin Express","content":"<p>Wai Yuen Tong Medicine Holdings Limited has scheduled a board meeting for 25 June 2026. The agenda includes consideration and approval of the audited consolidated results for the financial year ended 31 March 2026 and deliberation on a potential final dividend.</p>\n<p>The notification, released on 11 June 2026, was signed by Company Secretary Ng Yee Man Fiona. The board currently comprises three executive directors—Tang Ching Ho, Tang Wai Man and Law Man Yee, Anita—alongside independent non-executive directors Li Ka Fai, David, Professor Sit Wing Hang and Professor Chan Wing Kwong.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wai Yuen Tong Sets 25 June Board Meeting to Approve FY 2026 Results and Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWai Yuen Tong Sets 25 June Board Meeting to Approve FY 2026 Results and Final Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-11 16:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wai Yuen Tong Medicine Holdings Limited has scheduled a board meeting for 25 June 2026. The agenda includes consideration and approval of the audited consolidated results for the financial year ended 31 March 2026 and deliberation on a potential final dividend.</p>\n<p>The notification, released on 11 June 2026, was signed by Company Secretary Ng Yee Man Fiona. The board currently comprises three executive directors—Tang Ching Ho, Tang Wai Man and Law Man Yee, Anita—alongside independent non-executive directors Li Ka Fai, David, Professor Sit Wing Hang and Professor Chan Wing Kwong.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00897","symbol_name":"位元堂","start_time":0,"source_url":"","article_id":"1132195558","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1132195558","pubTimestamp":1781167438,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Wai Yuen Tong Medicine Holdings Limited has scheduled a board meeting for 25 June 2026. The agenda includes consideration and approval of the audited consolidated results for the financial year ended...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00897":"位元堂"},"translate_title":"位元堂定于6月25日召开董事会批准2026财年业绩及末期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00897":1},"content_text":"Wai Yuen Tong Medicine Holdings Limited has scheduled a board meeting for 25 June 2026. The agenda includes consideration and approval of the audited consolidated results for the financial year ended 31 March 2026 and deliberation on a potential final dividend.\nThe notification, released on 11 June 2026, was signed by Company Secretary Ng Yee Man Fiona. The board currently comprises three executive directors—Tang Ching Ho, Tang Wai Man and Law Man Yee, Anita—alongside independent non-executive directors Li Ka Fai, David, Professor Sit Wing Hang and Professor Chan Wing Kwong.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}